does glp-1 decrease muscle mass Weight loss and building progress with Muscle matters: the effects of

Headaches during GLP-1 therapy represent one of several potential side effects that warrant careful monitoring and provider communication

In one study, people who slowly tapered off the meds over the course of nine weeks were able to continue losing weight during the tapering period

The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes

The Therapeutic Goods Administration (TGA) has confirmed Ozempic's supply shortage in Australia is now resolved, meaning more patients than ever are starting treatment

Doctors and health experts now see natural GLP-1 activation as a safer, sustainable alternative to medications